Table 2.
Changes in BCVA (logMAR) and CFT (μm) at baseline vs. different time points post-treatment in the IVC+PRP group.
BCVA | Baseline | 6 m | 12 m | 18 m | 24 m | CFT | Baseline | 6 m | 12 m | 18 m | 24 m |
---|---|---|---|---|---|---|---|---|---|---|---|
n = 50 | 0.65 ± 0.15 | 0.53 ± 0.15 | 0.52 ± 0.13 | 0.49 ± 0.15 | 0.55 ± 0.14 | 470.91 ± 44.14 | 303.77 ± 37.54 | 306.62 ± 35.86 | 297.63 ± 30.71 | 307.35 ± 32.17 | |
t | 4.30 | 4.70 | 5.29 | 3.75 | 20.40 | 20.43 | 22.79 | 21.18 | |||
P | < 0.01 | < 0.01 | < 0.01 | < 0.01 | < 0.01 | < 0.01 | < 0.01 | < 0.01 |
BCVA, best-corrected visual acuity; CFT, central foveal thickness; m, months.